SEC Form 25-NSE filed by FutureTech II Acquisition Corp.

7/11/25 5:02:31 PM ET

$FTII

Blank Checks

Finance

Get the next $FTII alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

333-261886

Issuer:	FutureTech II Acquisition Corp.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	128 Gail Drive
	New Rochelle	NEW YORK	10805
Telephone number:				(914) 316-4805

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Class A Common Stock, Warrants and Units

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-07-11	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $FTII alert in real time by email

SEC Form 25-NSE filed by FutureTech II Acquisition Corp.

7/11/25 5:02:31 PM ET

$FTII

Blank Checks

Finance

Get the next $FTII alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

333-261886

Issuer:	FutureTech II Acquisition Corp.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	128 Gail Drive
	New Rochelle	NEW YORK	10805
Telephone number:				(914) 316-4805

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Class A Common Stock, Warrants and Units

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

2025-07-11	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $FTII alert in real time by email

SEC Form 25-NSE filed by FutureTech II Acquisition Corp.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$FTII

SEC Form 25-NSE filed by FutureTech II Acquisition Corp.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for
$FTII

$FTII
Press Releases

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

$FTII
SEC Filings

SEC Form 10-Q filed by FutureTech II Acquisition Corp.

FutureTech II Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

FutureTech II Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

$FTII
Insider Trading

CEO & CFO Chen Ray Lei converted options into 380,000 shares (SEC Form 4)

Large owner Radu Zachary C. converted options into 2,445,000 shares (SEC Form 4)

Director Bush Neil converted options into 10,000 shares (SEC Form 4)

$FTII
Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

SEC Form SC 13G filed by FutureTech II Acquisition Corp.

SEC Form 25-NSE filed by FutureTech II Acquisition Corp.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for $FTII

SEC Form 25-NSE filed by FutureTech II Acquisition Corp.

Crush Q3 2025 with the Best AI Superconnector

Recent Analyst Ratings for $FTII

$FTII Press Releases

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

$FTII SEC Filings

SEC Form 10-Q filed by FutureTech II Acquisition Corp.

FutureTech II Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

FutureTech II Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

$FTII Insider Trading

CEO & CFO Chen Ray Lei converted options into 380,000 shares (SEC Form 4)

Large owner Radu Zachary C. converted options into 2,445,000 shares (SEC Form 4)

Director Bush Neil converted options into 10,000 shares (SEC Form 4)

$FTII Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

SEC Form SC 13G filed by FutureTech II Acquisition Corp.

Recent Analyst Ratings for
$FTII

Recent Analyst Ratings for
$FTII

$FTII
Press Releases

$FTII
SEC Filings

$FTII
Insider Trading

$FTII
Large Ownership Changes